Track Record - 3.8x Average MOIC, 12 Exits, $500M+ AUM | JengaLabs Venture Capital PerformanceSkip to main content
📊 Top-Quartile Performance Since 2015

Consistent, Top-Tier Returns

3.8x average MOIC across 3 funds, 12 successful exits, and $500M+ in assets under management. Building long-term value for our LPs.

3.8x
Average MOIC
Across all funds
$500M+
Assets Under Management
Across 3 funds
12
Successful Exits
M&A + IPOs
Top 10%
VC Performance
Cambridge Associates

Fund Performance

Consistent top-quartile returns across three funds and nine years of investing

Fund I

Vintage 2015 • Fully Realized

4.2x
Fund Size
$50M
Status
100% Realized
DPI
4.2x
TVPI
4.2x
Companies Invested 15
Successful Exits 8
Avg Hold Period 5.2 years
IRR 38%
Notable Exits
DataFlow AI (IPO) 15.2x
RoboSurgix → Medtronic 12.4x

Fund II

Vintage 2018 • Partially Realized

3.8x
Fund Size
$120M
Status
65% Realized
DPI
2.5x
TVPI
3.8x
Companies Invested 18
Exits to Date 4
Active Investments 14
IRR (Current) 32%
Top Performing (Unrealized)
ZeroTrust Labs (Pre-IPO) 18.2x
LongevityBio (Series C) 11.3x

Fund III

Vintage 2021 • Active Deployment

2.9x
Fund Size
$200M
Status
25% Realized
DPI
0.7x
TVPI
2.9x
Companies Invested 12
Follow-On Rounds 7
Deployed Capital $145M (72%)
IRR (Current) 28%
Rising Stars
NeuroLink AI (Series B) 8.2x
GeneEdit Pro (Series B) 9.7x
💎 NOW RAISING

Fund IV - $150M Target

Building on our track record of consistent returns, we're raising our fourth fund to continue backing the next generation of deep tech startups.

$150M
Target Fund Size
$85M
Committed to Date
57%
Funded
Q2 2024
First Close

Exit History

12 successful exits including acquisitions by Fortune 500 companies and public offerings

D

DataFlow AI

✓ IPO • NASDAQ:DFLW

Exit Year
2022

AI-powered data analytics platform. IPO at $2.1B market cap on NASDAQ. Now trading at $3.8B valuation. Serving 5,000+ enterprise customers.

Investment
$3M
Exit Value
$48M
MOIC
15.2x
Hold
4.5 yrs
Fund I • Seed Investment AI
R

RoboSurgix

✓ ACQUIRED BY MEDTRONIC

Exit Year
2023

AI-powered surgical robotics platform. Acquired by Medtronic for $680M. FDA-approved system deployed in 200+ hospitals worldwide.

Investment
$5M
Exit Value
$62M
MOIC
12.4x
Hold
5.2 yrs
Fund I • Series A Investment Robotics
B

BioSynth Labs

✓ ACQUIRED BY ROCHE

Exit Year
2021

Synthetic biology platform for drug discovery. Acquired by Roche for $890M. Platform used to develop 12+ therapeutic candidates.

Investment
$7M
Exit Value
$79M
MOIC
11.3x
Hold
6.1 yrs
Fund I • Seed Investment Bio-Eng
C

CloudDefend

✓ ACQUIRED BY PALO ALTO

Exit Year
2023

Cloud security SaaS platform. Acquired by Palo Alto Networks for $420M. Protecting 5,000+ cloud workloads globally at time of acquisition.

Investment
$4M
Exit Value
$35M
MOIC
8.7x
Hold
3.8 yrs
Fund II • Series A Investment Cyber
Q

QuantumChip

✓ ACQUIRED BY INTEL

Exit Year
2020

Quantum computing hardware. Acquired by Intel for $310M. Technology integrated into Intel's quantum research division.

Investment
$4M
Exit Value
$27M
MOIC
6.8x
Hold
4.2 yrs
Fund I • Series A Investment AI
G

GridTech Solutions

✓ ACQUIRED BY SIEMENS

Exit Year
2019

Smart grid management software. Acquired by Siemens Energy for $245M. Platform managing 10+ GW of renewable energy capacity.

Investment
$3M
Exit Value
$18M
MOIC
5.8x
Hold
4.5 yrs
Fund I • Seed Investment Energy

+ 6 additional exits (2017-2023)

View Full Portfolio

Performance by Sector

Strong returns across all 6 investment sectors

🤖

AI

4.8x
Companies 12
Deployed $180M
Exits 3
Avg IRR 42%
🦾

Robotics

6.2x
Companies 8
Deployed $95M
Exits 2
Avg IRR 48%
🚀

Space

3.1x
Companies 6
Deployed $72M
Exits 1
Avg IRR 25%
🔒

Cyber

5.4x
Companies 10
Deployed $142M
Exits 3
Avg IRR 38%
🧬

Bio-Eng

7.1x
Companies 5
Deployed $58M
Exits 2
Avg IRR 52%
âš¡

Energy

2.8x
Companies 4
Deployed $48M
Exits 1
Avg IRR 22%

Invest in the Future of Technology

Join 100+ institutional investors and family offices backing the next generation of breakthrough companies.

$500K minimum commitment
10-year fund term
Quarterly reporting